Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide and Rituximab for relapsed CLL/SLL/PLL or NHL after transplant
NCT01419795Phase 2Terminated
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- May 2012
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), prolymphocytic leukemia (PLL), non-Hodgkin lymphoma (NHL), sponsored by Fred Hutchinson Cancer Center. Started May 2012; status: terminated.
02
Drugs
lenalidomide
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)prolymphocytic leukemia (PLL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT01419795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01419795.